There have been three deaths and no serious injuries tied to a problem affecting detection of the pumps, according to Abiomed ...

The FDA has issued an alert about a potentially high-risk issue involving Abiomed’s Automated Impella Controller, which is used with the company’s blood pump systems. Abiomed, now part of Johnson & ...

The cumulative access limits under the RFI regular window and the RCF exogenous shock window, previously at 150 percent of quota, will be increased to 175 percent of quota for members that will borrow ...